secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2023-04-18T23:59:59+00:00
Accession:  0001104659-23-046443
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anzu SPAC I signs definitive merger with Envoy Medical at 15M share valuation; $10M PIPE from sponsor
--------------------------------------------------------------------------------

- Anzu SPAC entered into a business combination agreement with Envoy Medical; Envoy valued at 15M shares of Anzu Class A common stock.
- Sponsor to invest $10M in PIPE for Series A Preferred Stock at $10/share with 12% dividend and conversion at $11.50.
- Sponsor to forfeit 10,010,000 Class B shares and all 12.5M private placement warrants at closing.
- Stockholders may exchange non-redeemed shares for Series A Preferred Stock in exchange offer.
- Deal subject to stockholder approval, HSR clearance, Nasdaq listing; outside date Sep 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000110465923046443/0001104659-23-046443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000110465923046443/tm2312890d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-046443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer